Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,012
datasets available to search
ShareScore release 0.9.0
Dataset results
2,012 results for “Kinase”
Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase Inhibitor
ClinicalTrials.gov study NCT01947868. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC
ClinicalTrials.gov study NCT06632106. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pyruvate Kinase Deficiency Global Longitudinal Registry Substudy of Protocol AG348-C-008
ClinicalTrials.gov study NCT04995315. IPD Sharing: NO. Countries: 3. Publications: 0.
A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Mye
ClinicalTrials.gov study NCT01236144. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT04845035. IPD Sharing: NO. Countries: 1. Publications: 0.
Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs
ClinicalTrials.gov study NCT01098500. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Pyridoxal Kinase Activity in Tardive Dyskinesia
ClinicalTrials.gov study NCT01908452. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT02616211. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/tyrosine Kinase Inhibitors with or Without TACE for Advanced HCC with Vascular Invasions
ClinicalTrials.gov study NCT06881446. IPD Sharing: Not stated. Countries: 1. Publications: 0.
P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain
ClinicalTrials.gov study NCT00390845. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease
ClinicalTrials.gov study NCT04541407. IPD Sharing: NO. Countries: 1. Publications: 0.
Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System
ClinicalTrials.gov study NCT05753384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/tyrosine Kinase Inhibitors with or Without HAIC for Advanced HCC
ClinicalTrials.gov study NCT06881433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Compassionate Case Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Su
ClinicalTrials.gov study NCT02174991. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs
ClinicalTrials.gov study NCT02712112. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations
ClinicalTrials.gov study NCT05445791. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell Malignancies
ClinicalTrials.gov study NCT04014205. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT05259228. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predicting the Response of Patients With Rheumatoid Arthritis to Treatment With Genetically Engineered Biological Drugs and Janus (JAK) Kinase Inhibitors
ClinicalTrials.gov study NCT06177405. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma
ClinicalTrials.gov study NCT00492986. IPD Sharing: Not stated. Countries: 11. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.